ALK Diluent

DRUG5 trials

Sponsors

Karolinska Institutet, Lars Olaf Cardell

Conditions

Allergic RhinitisAllergic Rhinitis Due to Grass PollenRhinitis, AllergicRhinitis, Allergic, Seasonal

Phase 1

Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass

CompletedNCT04296474

Lars Olaf CardellAllergic Rhinitis

Start: 2018-05-15End: 2022-07-01Updated: 2022-09-21

Phase 2

Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy

CompletedNCT02423707

Karolinska InstitutetAllergic Rhinitis

Start: 2010-08-31End: 2017-12-31Updated: 2018-08-20

Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy

CompletedNCT02679105

Karolinska InstitutetRhinitis, Allergic

Start: 2015-05-31End: 2019-03-31Updated: 2019-09-04

Intralymphatic Immunotherapy in Increasing Doses, Substudy

CompletedNCT02975479

Karolinska InstitutetRhinitis, Allergic, Seasonal

Start: 2016-05-31End: 2022-06-20Target: 40Updated: 2022-06-24

Is Intralymphatic Allergen Immunotherapy Effective and Safe?

CompletedNCT04210193

Lars Olaf CardellAllergic Rhinitis Due to Grass Pollen

Start: 2014-04-25End: 2019-12-01Updated: 2019-12-24

Related Papers

A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy

Allergy Asthma and Clinical Immunology2020-04-2823 citations